RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR+21.5%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+21.5%/yr
vs -25.7%/yr prior
Acceleration
+47.2pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 57.96% |
| 2023 | -89.21% |
| 2022 | -21.70% |
| 2021 | 32.34% |
| 2020 | 581.23% |
| 2019 | -27.00% |
| 2018 | 193.62% |
| 2017 | 106.18% |
| 2016 | -38.38% |
| 2015 | -468.86% |